{
 "as_of": "2026-11-11",
 "cmr": "nl-cm-kg/XAMS/NL0010391025",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# PHARMING GROUP (Euronext Amsterdam: NL0010391025) — research page\n\nAs of 2026-11-11 · nl-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is PHARMING GROUP, listed on Euronext Amsterdam under ticker NL0010391025, with ISIN NL0010391025 and LEI 724500DCJ9MPG74JEH91. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). Its segment is not on the record, and its sector is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 54 filings in the window 2025-11-11 to 2026-11-11, falling on 26 filing days. The filings are 15 ad hoc, 4 AGM/EGM, 8 directors' dealings, 15 newswire releases and 12 results. The median gap between filing days is 8 days. The latest filing is a newswire release dated 2026-11-06, 5 days before the record date of 2026-11-11. On Euronext Amsterdam the record holds 123 issuers with a median cadence gap of 10.2 days, a median of 15 filings and a median latency of 7.0 days. The sector median is not on the record.\n\n## Auditor\n\nThe auditor is not on the record. The record carries the annual report link only, as a source link and not a read. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule version acm-68000/nl/mifid-ii-product-governance/r1, with chapter as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nThe issuer's investor-relations page names 8 research houses: Oppenheimer & Co. Inc., Portzamparc / BNP Paribas, Canaccord Genuity, First Berlin Research, H.C. Wainwright, Jefferies, Van Lanschot Kempen and RBC Capital Markets.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)\n- https://api.gleif.org/api/v1/lei-records/724500DCJ9MPG74JEH91 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.nl-cm-kg.ai/events/XAMS/NL0010391025 (the disclosure lines)\n- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)\n- https://mcp.nl-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.pharming.com/investors/analyst-coverage (coverage)\n- https://mcp.nl-cm-kg.ai/record/XAMS/NL0010391025 (the record)\n",
 "market": "NL",
 "node": "nl-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the NL vintage is not sealed; the record is the live record as of 2026-11-11",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "NL",
    "reason": "Width 0 records the annual report link only (ORDER-016: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "NL",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "NL",
    "state": "not_on_record"
   },
   "changes": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "nl-cm-kg/XAMS/NL0010391025",
  "coverage": {
   "count": 8,
   "houses": [
    {
     "analyst": "Joseph Pantginis",
     "house": "Oppenheimer & Co. Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Mohamed Kaabouni",
     "house": "Portzamparc / BNP Paribas",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Whitney Ijem",
     "house": "Canaccord Genuity",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Simon Scholes",
     "house": "First Berlin Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Joseph Pantginis",
     "house": "H.C. Wainwright",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Benjamin Jackson",
     "house": "Jefferies",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Sushila Hernandez",
     "house": "Van Lanschot Kempen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Harry Sephton",
     "house": "RBC Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharming.com/investors/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.pharming.com/investors/analyst-coverage",
     "result": "read: 8 of 13 named houses found on the page"
    },
    {
     "page": "https://www.pharming.com/sites/default/files/imce/Press%20releases/Initiating-Coverage-Report-van-Leuwenhoeck.04.09.17.pdf",
     "result": "not readable by this rail (404)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 123,
     "median_cadence_gap_days": 10.2,
     "median_filings": 15,
     "median_latency_days": 7,
     "name": "Euronext Amsterdam"
    },
    "sector": {
     "market": "NL",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "ad_hoc": 15,
    "agm_egm": 4,
    "directors_dealings": 8,
    "newswire_release": 15,
    "results": 12
   },
   "cadence_median_gap_days": 8,
   "filing_days": 26,
   "filings": 54,
   "latency_days": 5,
   "latest": [
    {
     "category": null,
     "date": "2026-11-06",
     "source": "https://www.globenewswire.com/news-release/2026/11/06/3397310/0/en/mhra-approves-pharming-s-joenja-leniolisib-as-first-treatment-specifically-for-children-with-apds-in-the-u-k.html",
     "title": "MHRA approves Pharming’s Joenja® (leniolisib) as first",
     "type": "newswire_release"
    },
    {
     "category": "inside information",
     "date": "2026-11-06",
     "source": "https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2501-01197",
     "title": "Azerion publishes the Notice of its Extraordinary General Meeting of 18 December 2026 regarding the appointment of new members to the Management and Supervisory Boards",
     "type": "agm_egm"
    },
    {
     "category": null,
     "date": "2026-10-27",
     "source": "https://www.globenewswire.com/news-release/2026/10/27/3388693/0/en/pharming-group-reports-third-quarter-2026-financial-results-strong-revenue-growth-joenja-apds-expansion-and-cvid-topline-data-in-november.html",
     "title": "Pharming Group reports third quarter 2026 financial",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-10-27",
     "source": "https://www.globenewswire.com/Resource/Download/0cb2b486-3c7d-4d09-a25a-6b26c15830ce",
     "title": "Pharming Group reports third quarter 2026 financial results",
     "type": "results"
    },
    {
     "category": "inside information",
     "date": "2026-10-27",
     "source": "https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2610-01349",
     "title": "Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November",
     "type": "results"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.nl-cm-kg.ai/events/XAMS/NL0010391025",
   "window": {
    "from": "2025-11-11",
    "to": "2026-11-11"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Euronext Amsterdam"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "confirmed",
    "value": "NL0010391025"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column) (registeredAt KVK)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/724500DCJ9MPG74JEH91",
    "state": "sourced",
    "value": "Netherlands (KVK-registered)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-12",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN NL0010391025)",
    "state": "sourced",
    "value": "724500DCJ9MPG74JEH91"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "PHARMING GROUP"
   },
   "sector": {
    "market": "NL",
    "reason": "no sector on the FIRDS record and no machine-readable register activity code",
    "state": "not_on_record"
   },
   "security_type": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "NL",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "NL0010391025"
   },
   "website": {
    "market": "NL",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "NL",
  "node": "nl-cm-kg",
  "numbers_hash": "sha256:9c5e5c140d6ba02b5bb84081e1e62b321bb5ed0dc17ec953cab6440f25abf76f",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.nl-cm-kg.ai/book/aio.json",
    "door": "https://mcp.nl-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/nl/mifid-ii-product-governance/r1",
   "section": "nl.aio.v11"
  },
  "record": {
   "as_of": "2026-11-11",
   "url": "https://mcp.nl-cm-kg.ai/record/XAMS/NL0010391025",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-12",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9c5e5c140d6ba02b5bb84081e1e62b321bb5ed0dc17ec953cab6440f25abf76f",
 "path": "/nl/XAMS/NL0010391025",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is PHARMING GROUP, listed on Euronext Amsterdam under ticker NL0010391025, with ISIN NL0010391025 and LEI 724500DCJ9MPG74JEH91. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). Its segment is not on the record, and its sector is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 54 filings in the window 2025-11-11 to 2026-11-11, falling on 26 filing days. The filings are 15 ad hoc, 4 AGM/EGM, 8 directors' dealings, 15 newswire releases and 12 results. The median gap between filing days is 8 days. The latest filing is a newswire release dated 2026-11-06, 5 days before the record date of 2026-11-11. On Euronext Amsterdam the record holds 123 issuers with a median cadence gap of 10.2 days, a median of 15 filings and a median latency of 7.0 days. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record. The record carries the annual report link only, as a source link and not a read. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule version acm-68000/nl/mifid-ii-product-governance/r1, with chapter as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 8 research houses: Oppenheimer & Co. Inc., Portzamparc / BNP Paribas, Canaccord Genuity, First Berlin Research, H.C. Wainwright, Jefferies, Van Lanschot Kempen and RBC Capital Markets.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/724500DCJ9MPG74JEH91"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.nl-cm-kg.ai/events/XAMS/NL0010391025"
  },
  {
   "for": "the halt flag",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.nl-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.pharming.com/investors/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.nl-cm-kg.ai/record/XAMS/NL0010391025"
  }
 ],
 "title": "PHARMING GROUP (NL0010391025) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}